Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 6/20 | 0.59 |
| ▸ | HTR2C | P28335 | 5/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.59 |
| ▸ | HTR1A | P08908 | 4/20 | 0.59 |
| ▸ | HTR2A | P28223 | 4/20 | 0.59 |
| ▸ | HTR2B | P41595 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | BLM | P54132 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.59 |
| ▸ | HTR7 | P34969 | 2/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.59 |
| ▸ | MTOR | P42345 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10821180 | 0.86 | NPSR1 (0.51) | NPSR1HTR2CCYP3A4HTR1AHTR2A | |
| SCHEMBL7292049 | 0.84 | NPSR1 (0.55) | NPSR1HTR2CCYP3A4HTR1AHTR2A | |
| SCHEMBL2494144 | 0.81 | HTR2C (0.52) | NPSR1HTR2CCYP3A4HTR1AHTR2A | |
| SCHEMBL9536748 | 0.81 | NPSR1 (0.56) | NPSR1HTR2CCYP3A4HTR1AHTR2A | |
| SCHEMBL30518932 | 0.79 | MEN1 (0.56) | HTR2CHTR2AHTR2BALDH1A1TSHR | |
| SCHEMBL6469548 | 0.79 | HTR2C (0.60) | NPSR1HTR2CCYP3A4HTR1AHTR2A | |
| SCHEMBL30518090 | 0.79 | MEN1 (0.56) | HTR2CHTR2AHTR2BALDH1A1TSHR | |
| SCHEMBL1349263 | 0.79 | MEN1 (0.56) | HTR2CHTR2AHTR2BALDH1A1TSHR | |
| SCHEMBL10079616 | 0.79 | MEN1 (0.56) | HTR2CHTR2AHTR2BALDH1A1TSHR | |
| SCHEMBL7289880 | 0.78 | NPSR1 (0.59) | NPSR1HTR2CCYP3A4HTR1AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11118011-B2 | Biocompatible polymers for medical devices | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2021-09-14 | — | — | US | disclosed |
| EP-3461855-B1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | UNIV RUTGERS (US) | 2020-05-27 | — | — | EP | disclosed |
| US-20190185624-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2019-06-20 | — | — | US | disclosed |
| EP-3461855-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | Rutgers, The State University of New Jersey (US) | 2019-04-03 | — | — | EP | disclosed |
| US-10202490-B2 | Biocompatible polymers for medical devices | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2019-02-12 | — | — | US | disclosed |
| EP-2486081-B1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | UNIV RUTGERS (US) | 2018-12-05 | — | — | EP | disclosed |
| US-20170158819-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2017-06-08 | — | — | US | disclosed |
| US-9605112-B2 | Biocompatible polymers for medical devices | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-03-28 | — | — | US | disclosed |
| US-20120226013-A1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2012-09-06 | — | — | US | disclosed |
| EP-2486081-A1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | Rutgers, The State University of New Jersey (US) | 2012-08-15 | — | — | EP | disclosed |
| WO-2011044567-A1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2011-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120226013-A1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | MATR3, MIF, BMP2 | NPSR1 1710/4885HTR2C 4306/4885CYP3A4 3629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.